Pharmacist Use of ECG to Inform Drug Therapy Decisions for Patients Receiving QT Prolonging Medications

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 11, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Torsades de Pointe Caused by Drug (Disorder)Torsades de PointesQt Interval, Variation in
Interventions
OTHER

Pharmacist Intervention

The pharmacist will record a 30 second rhythm strip from patients using the KardiaMobile device and calculate the QTc interval using the Bazett calculation formula. The pharmacist will discuss the result with the patient and if necessary, will contact the prescriber to effect a medication change. If the QTc interval is greater than the 99th percentile, (470 ms for males, 480 ms for females) the pharmacist must contact the prescriber. The pharmacist will record any prescription changes which resulted from the intervention and the prescriber response. The pharmacist will email the rhythm strip (with study participation number) to a secure email at the Northeast Iowa Family Practice Center (NEIFPC). Rhythm strips will be archived for future potential research evaluation in a secure, electronic file.

Trial Locations (1)

50702

Northeast Iowa Family Practice, Waterloo

All Listed Sponsors
lead

Northeast Iowa Medical Education Foundation

OTHER

NCT04000542 - Pharmacist Use of ECG to Inform Drug Therapy Decisions for Patients Receiving QT Prolonging Medications | Biotech Hunter | Biotech Hunter